期刊文献+

NGAL在择期冠状动脉介入术后早期肾损害中临床应用价值的初步探讨 被引量:2

The clinical significance of neutrophil gelatinase-associated lipocalin in early kidney injury after elective percutaneous coronary intervention
原文传递
导出
摘要 目的 探讨免疫透射比浊法测定的中性粒细胞明胶酶相关脂质运载蛋白(NGAL)在择期冠状动脉介入治疗术后早期肾损害中的临床应用价值.方法 临床病例对照研究.收集2013年4至8月于泰达国际心血管病医院接受冠状动脉介入术治疗的稳定性心绞痛及急性冠状动脉综合征患者201例.用酶法测定所有入选患者术前及术后2、4、8、24、48 h血肌酐值;用免疫透射比浊法测定所有入选患者术前及术后2、4、8、24h血NGAL值及术前、术后8和24h尿NGAL值.将发生对比剂肾病(CIN)的患者纳入病例组,在入选患者中按1∶4比例选取未发生对比剂肾病的患者纳入对照组,两组正态分布的定量资料采用t检验,非正态分布的定量资料采用非参数秩和检验进行比较.结果 201例患者中发生CIN的患者8例,发病率为3.98%.ROC曲线分析发现,各时段血NGAL中术后2h、8h血NGAL曲线下面积(AUC)均大于0.9,术后2h血NGAL的AUC为0.928,95%可信区间(CI)0.800 ~0.985,以109 ng/ml为诊断截点时,其在CIN诊断中的敏感度和特异度分别为87.5%和100%;术后8h血NGAL的AUC为0.945,95% CI0.824~0.992,以96 ng/ml为诊断截点时,其在CIN诊断中的敏感度和特异度分别为87.5%和87.5%.各时段尿NGAL中术后8h尿NGAL的AUC最大为0.969,95% CI0.859 ~0.999,以91 ng/ml为诊断截点时,其在CIN诊断中的敏感度和特异度分别为87.5%和100%.结论 血、尿NGAL对CIN的早期诊断价值早于血肌酐,可作为择期冠状动脉介入术后早期肾损害的预测指标. Objective To explore the clinical application value of neutrophil gelatinase-associated lipocalin( NGAL)which were tested by immunity transmission turbidity in early kidney injury after elective percutaneous coronary intervention. Methods A case-control study was conducted. All 201 stable angina pectoris and acute coronary syndrome patients undergone percutaneous coronary intervention in TEDA International Cardiovascular Hospital, during April to August 2013, were enrolled in this study. Before and 2 h,4 h,8 h,24 h,48 h after the operation, the plasma creatinine of the patient samples were tested by enzymic method. Before and 2 h, 4 h, 8 h, 24 h after the operation, the plasma NGAL was tested by immunity transmission turbidity method. Before and 8 h, 24 h after the operation, the urinary NGAL was tested by immunoturdimetric method. The data were compared between contrast induced nephrpathy (CIN) and non-CIN groups. For normal distribution of quantitative data, t test were used and for non-normal distribution of quantitative data, nonparametric rank and inspection were used. Results CIN occurred in 8 of 201 enrolled patients, the incidence was 3.98%. Receiver operating characteristic curve (ROC) analysis confirmed the diagnostic accuracy of the plasma NGAL in CIN, and the area under the curve(AUC) of 2 h plasma NGAL was 0. 928,95% CI 0. 800 -0. 985 ,with the cut-off value NGAL as 109 ng/ml, the diagnosticsensitivity and specificity for CIN were 87.5% and 100% ;the AUC of 8 h plasma NGAL was 0. 945,95% CI 0. 824 -0. 992,with the cut-off value NGAL as 96 ng/ml, the diagnostic sensitivity and specificity for CIN were 87.5% and 87.5% ;the AUC of 8 h urinary NGAL was 0. 969, 95% CI 0. 859 - 0. 999 , with the cut- off value NGAL as 91 ng/ml, the diagnostic sensitivity and specificity for CIN were 87.5% and 100%. Conclusions The change of plasma and urinary NGAL is earlier to that of serum creatinine for the early diagnosis of CIN. It can be used as the predictor of early renal damage after elective coronary artery interventional.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2014年第7期517-521,共5页 Chinese Journal of Laboratory Medicine
基金 天津市卫生局科技基金资助项目(2011KZ14)
关键词 急相蛋白质类 经皮冠状动脉介入术 肾疾病 Acute-phase proteins Percutaneous coronary intervention Kidney diseases
  • 相关文献

参考文献17

  • 1Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention[ J]. Circulation, 2002,105 : 2259-2264.
  • 2Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency[ J]. Am J Kidney Dis,2002,39: 930-936.
  • 3Budano C,Levis M,D'Amico M, et al. Impact of contrast-induced acute kidney injury definition on clinical outcomes [ J ]. Am Heart J,2011,161 : 963-971.
  • 4杨莉.急性肾损伤[J].中华检验医学杂志,2011,34(5):476-480. 被引量:21
  • 5Munir MU, Khan DA, Khan FA, et al. Rapid detection of acute kidney injury by urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass surgery [ J ]. J Coil Physicians Surg Pak ,2013,23 : 103-106.
  • 6Liebetrau C, D~rr O, Baumgarten H, et al. Neutrophil gelatinase- associated lipocalin for the early detection of cardiac surgery associated acute kidney injury [ J ]. Scand J Clin Lab Invest,2013, 73 : 392-399.
  • 7Alearaz A J, Gil-Ruiz MA, Castillo A, et al. Postoperative neutrophil gelatinase-associated lipocalin predicts acute kidney injury after pediatric cardiac surgery[J]. Pediatr Crit Care Med, 2014,15: 121-130.
  • 8Peco-Anti6 A, Ivani~evi/~ I, Vuli6evi6 I, et al. Biomarkers of acute kidney injury in pediatric cardiac surgery [ J ]. Clin Biochem, 2013,46 : 1244-1251.
  • 9Devarajan P. Review: Neutrophil gelatinase-associated lipocalin :A troponin-like biomarker for human acute kidney injury [J]. Nephrology (Carlton) ,2010,15 : 419428.
  • 10de Geus HR, Betjes MG, Bakker J. Biomarkers for the prediction of acute kidney injury : a narrative review on current status and future challenges[J]. Clin Kidney J,2012,5: 102-108.

二级参考文献36

  • 1Toprak O.What is the best definition of contrast-induced nephropathy[J].Ren Fail,2007,29(3):387-388.
  • 2Hirsch R.NGAL is an early predictive biomarker of contrast-induced nephropathy in children[J].Pediatr Nephrol,2007,22(12):2089-2095.
  • 3Person PB,Hansell P,Liss P.Pathophysiology of contrast medium-induced nephropathy[J].Kidney Int,2005,68(1):14-22.
  • 4Mishra J,Dent C,Tarabishi R,et al.Neutrophil gelatinase-associated lipocalin(NGAL)as a biomarker for acute renal injury after cardiac surgery[J].Lancent,2005,365(9466):1231-1238.
  • 5Pannu N,Wiebe N,Tonelli M.Prophylaxis strategies for contrast-induced nephropathy[J].JAMA,2006,295(23):2765-2779.
  • 6Harjai KJ,Raizada A,Shenoy C,et al.A comparison of contemporary definitions of contrast nephropathyin patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system[J].Am J Cardiol,2008,101(6):812-819.
  • 7Heyde GS,Koch KT,de Winter RJ,et al.Randomized trial comparing same-day discharge with overnight hospital stay after percutaneous coronary intervention:results of the Elective PCI in Outpatient Study (EPOS)[J].Circulation,2007,115(17):2299-2306.
  • 8Toprak O.Risk factors and therapy strategies for contrast-inducednephropathy[J].Ren Fail,2006,28(5):365-381.
  • 9Kimmel M,Butscheid M,Brenner G,et al.Improved estimation of glomerular filtration ate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results[J].Nephrol Dial Transplant,2008,23(4):1241-1245.
  • 10Kellum JA, Levin N, Bouman C, et al. Developing a consensus classification system for acute renal failure. Curr Opin Crit Care,2002, 8:509-514.

共引文献22

同被引文献30

  • 1薛文鑫,李静,李怡文,张藜莉.强化瑞舒伐他汀对经皮冠脉介入术后对比剂肾病预防效果的Meta分析[J].中国生化药物杂志,2014,34(6):83-86. 被引量:8
  • 2崔勇,王蔚副,葛均波.All About ACS——急性冠脉综合征治疗掼解读[J].中国处方药,2006(11):4-9. 被引量:17
  • 3无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2090
  • 4Darwish T. An evidence-based approach to minimise con- trast induced nephropathy [J]. N Z Med J,2009,122(1299) : 39-41.
  • 5Madrazo GZ, Arias GM. Contrast nephropathy. Review and prophylaxis !1I [J]. Rev Clin Esp,2008,208 (10):517- 519.
  • 6Zager RA, Johnson AC, Hanson SY. Radiographic contrast media-induced tubular injury:evaluation of oxidant stress and plasma membrane integrity [J]. Kidney Int,2003,64 ( 1 ) : 128-139.
  • 7陈纪言.对比剂肾病发病机制的深入探索[J].中国医学论坛报,2009,35(30):59-62.
  • 8Hefts BR, Schneider E, 0buchowski N, et al. Probability of reduced renal function after contrast-enhanced CT:a model based on serum creatinine level,patient age,and estimated glomerular filtration rate [J]. AJR Am Roentgenol, 2009,193(2) :494-500.
  • 9Jo SH, Koo BK, Park JS, et al. Prevention of radiocontrast medium-induced nephropathy using short-term high- dose simvastatin in patients with renal insufficiency un- dergoing coronary angiography (PROMISS)trial-a ran- domized controlled study [J]. Am Heart J,2008,155(3): 499, e 1-eS.
  • 10Konstantinos S, Elias A, Stamatis K, et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or in- tervention [J]. Circulation, 2004,110(18) : 2837-2842.

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部